15 research outputs found
Recommended from our members
CommunityRx, a social care assistance intervention for family and friend caregivers delivered at the point of care: Two concurrent blinded randomized controlled trials
Background: CommunityRx is an evidence-based social care intervention delivered to family and friend caregivers (“caregivers”) at the point of healthcare to address health-related social risks (HRSRs). Two CommunityRx randomized controlled trials (RCTs) are being fielded concurrently on Chicago’s South Side, a predominantly African American/Black community. CommunityRx-Hunger is a double-blind RCT enrolling caregivers of hospitalized children. CommunityRx-Dementia is a single-blind RCT enrolling caregivers of community-residing people with dementia. RCTs with caregivers face recruitment barriers, including caregiver burden and lack of systematic strategies to identify caregivers in clinical settings. COVID-19 pandemic-related visitor restrictions exacerbated these barriers and prompted the need for iteration of the protocols from in-person to remote operations. This study describes these protocols and methods used for successful iteration to overcome barriers. Methods and findings: CommunityRx uses individual-level data to generate personalized, local community resource referrals for basic, health and caregiving needs. In early 2020, two in-person RCT protocols were pre-tested. In March 2020, when pandemic conditions prohibited face-to-face clinical enrollment, both protocols were iterated to efficient, caregiver-centered remote operations. Iterations were enabled in part by the Automated Randomized Controlled Trial Information-Communication System (ARCTICS), a trial management system innovation engineered to integrate the data collection database (REDCap) with community resource referral (NowPow) and SMS texting (Mosio) platforms. Enabled by engaged Community Advisory Boards and ARCTICS, both RCTs quickly adapted to remote operations. To accommodate these adaptations, launch was delayed until November (CommunityRx-Hunger) and December (CommunityRx-Dementia) 2020. Despite the delay, 65% of all planned participants (CommunityRx-Hunger n = 417/640; CommunityRx-Dementia n = 222/344) were enrolled by December 2021, halfway through our projected enrollment timeline. Both trials enrolled 13% more participants in the first 12 months than originally projected for in-person enrollment. Discussion: Our asset-based, community-engaged approach combined with widely accessible institutional and commercial information technologies facilitated rapid migration of in-person trials to remote operations. Remote or hybrid RCT designs for social care interventions may be a viable, scalable alternative to in-person recruitment and intervention delivery protocols, particularly for caregivers and other groups that are under-represented in traditional health services research. Trial registration: ClinicalTrials.gov: CommunityRx-Hunger (NCT04171999, 11/21/2019); CommunityRx for Caregivers (NCT04146545, 10/31/2019).</p
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs
BACKGROUND:
Approximately 60 million people in the United States live with one of four chronic conditions: heart disease, diabetes, chronic respiratory disease, and major depression. Anxiety and depression are very common comorbidities in COPD and have significant impact on patients, their families, society, and the course of the disease.
METHODS:
We report the proceedings of a multidisciplinary workshop on anxiety and depression in COPD that aimed to shed light on the current understanding of these comorbidities, and outline unanswered questions and areas of future research needs.
RESULTS:
Estimates of prevalence of anxiety and depression in COPD vary widely but are generally higher than those reported in some other advanced chronic diseases. Untreated and undetected anxiety and depressive symptoms may increase physical disability, morbidity, and health-care utilization. Several patient, physician, and system barriers contribute to the underdiagnosis of these disorders in patients with COPD. While few published studies demonstrate that these disorders associated with COPD respond well to appropriate pharmacologic and nonpharmacologic therapy, only a small proportion of COPD patients with these disorders receive effective treatment.
CONCLUSION:
Future research is needed to address the impact, early detection, and management of anxiety and depression in COPD
Depression and Anxiety of Care Partners During the Emergency Department Visit of Older Adults with Cognitive Impairment
Introduction: Older adults with cognitive impairment (CI) are more likely to visit the emergency department (ED) than those without CI. They are also more likely to suffer poor outcomes after an ED visit. Family and friends who serve as care partners contribute significant time and resources to the care of these patients and may need particular attention to their emotional needs during and after the ED encounter. In this study, we examined the association between patient and care partner characteristics on care partner depression and anxiety at the time of the ED visit. Methods: Baseline data from 640 patient-care partner dyads who were enrolled in a two-site randomized controlled trial at New York University Lagone Health and Indiana University. The goal of the trial was to evaluate a tailored collabotative care management program to reduce readmissions of ED patients older than 75 years with CI and reduce care partner burden. Eligible patients were ED patients aged ≥75 years with CI as measured by the Mini-Cog or the proxy-reported Short Informant Questionnaire on Cognitive Decline in the Elderly and a planned dicharge home. Eligble care partners were self-identified or identified by the patient. We collected patient and care partner demographics, care partner-reported patient medical and psychiatric history, daily needs of the patient, and patient-care partner relationship. We used descriptive statistics and logistic regression to identify factors associated with symptoms of depression or anxiety in care partners, as assessed by Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder (GAD-7) scores, respectively. Results: Depression and anxiety data were available on all 640 care partners. In total, 251 (39.2%) had depression as measured by a score of ≥5 on the PHQ-9 and 299 (46.7%) had anxiety based on a score ≥5 on the GAD-7. Patient functional impairment (OR 1.04, 95% CI 1.01, 1.07), behavioral and psychological symptoms (OR 1.08, 95% CI 1.04, 1.13) and care partner social support (OR 0.91, CI 0.88, 0.95) were significantly associated with care partner depression. Similarly, patient functional impairment (OR 1.04, 95% CI 1.01, 1.07), behavioral and psychological symptoms (OR 1.11, 95% CI 1.07, 1.16) and care partner social support (OR 0.94, CI 0.90, 0.97) were also significantly associated with care partner anxiety as was patient race (p=0.041). Conclusion: Care partners of older adults with CI who present to the ED demonstrate depression and anxiety, but discharge from the ED represents an opportunity to focus on integration of care partners into aftercare in a well-informed, supportive fashion